Posted in | News | Fibre Optics

Low Latency Solution of Infinera to be Used by Spread Networks

Infinera has announced that Spread Networks has approved their low latency solution to be used in a fiber route between New York and Chicago. The 825 fiber miles will have a round trip latency of less than 13.33 ms, which has been developed by Spread Networks particularly for financial institutions. The optimal latency solution would decrease the equipment drag on the dark fiber of Spread by over 80%, in comparison to traditional DWDM solutions.

Infinera is a leading provider in the optical network market of North America. It provides a flexible, low-latency platform for financial institutions, which can be used in high-frequency trading applications. The network services of Infinera offer benefits such as 24x7x365 monitoring, 30-min mean time to repair and 24-h circuit turn-up.

The low latency solution of Infinera features ultra fast transponders and latency-optimized optical amplifiers. The low latency transponders add 10 ns to a data stream, which Infinera says is faster than that of its competitors by 5-10x. The Raman optical amplifiers decrease latency by more than 60% by streamlining the extension of light across networks.

The solution also contains Fiber Bragg Grating dispersion compensation, which will save 200 to 1000 µs between New York and Chicago when compared to traditional dispersion compensation coils.

Chief Executive Officer of Spread Networks, David Barksdale said that the company was delighted to have Infinera as an optical equipment provider. He further commented that Infinera always provides a solution that is of high quality and meets the demanding expectations of the customer.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.